ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2018
A Prospective Study of Aspirin Use and Prostate Cancer Risk by
Konrad H Stopsack, Amparo G Gonzalez-Feliciano, Samuel F Peisch, Mary K Downer, Riley A Gage, Stephen Finn, Rosina T Lis, Rebecca E Graff, Andreas Pettersson, Claire H Pernar and 5 more
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors at 6 institutions in 3 countries.
Konrad H StopsackDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. stopsack@mskcc.org.ORCID 0000-0002-0722-1311
Amparo G Gonzalez-FelicianoDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Samuel F PeischDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Mary K DownerDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Riley A GageDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Stephen FinnDepartment of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-8628-5814
Rosina T LisDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Rebecca E GraffDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0003-0316-8303
Andreas PetterssonDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Claire H PernarDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Massimo LodaDepartment of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Philip W KantoffDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Thomas U AhearnNational Cancer Institute, Division of Cancer Epidemiology and Genetics, Epidemiology and Biostatistics Program, Bethesda, Maryland.
Lorelei A Mucci
Transdisciplinary Prostate Cancer Partnership (ToPCaP)
Harvard University · USBrigham and Women's Hospital · USMemorial Sloan Kettering Cancer Center · USDana-Farber Cancer Institute · USNational Cancer Institute · USTrinity College Dublin · IE
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6M
Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate CanceP50CA090381 · NCI · DANA-FARBER CANCER INSTITUTE · PI KANTOFF, PHILIP W · 2002 to 2017
$36.2M
Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
Cancer Epidemiology Cohort in Male Health ProfessionalsU01CA167552 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Lorelei Mucci, Walter C. Willett · 2017 to 2026
$17.0M
Cancer Epidemiology Cohort in Male Health ProfessionalsUM1CA167552 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2012 to 2016
$11.5M
Training in Molecular& Genetic Epidemiology of CancerR25CA112355 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTE, JOHN S. · 2005 to 2018
$6.5M
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer ProgressionR01CA136578 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI MUCCI, LORELEI · 2009 to 2013
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Prospective Study of Aspirin Use and Prostate Cancer Risk by · full record | OpenQuestion